Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam versus sodium valproate versus propranolol for pediatric migraine prevention
IRCT20160802029171N3Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in migraine comparing Levetiracetam, Sodium valproate and Propranolol (3 arms). Primary endpoints: Headache severity, Headache frequency and 1 more. Started Feb 2018; status: completed.
02
Drugs
levetiracetamvalproic acidpropranolol
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20160802029171N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160802029171N3.